BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18360718)

  • 21. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor.
    Qian RZ; Yue F; Zhang GP; Hou LK; Wang XH; Jin HM
    Chin Med J (Engl); 2008 Dec; 121(24):2599-603. PubMed ID: 19187602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
    Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P; Marusic J; Stattin P; Bergh A
    Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor volume of colon carcinoma is related to the invasive pattern but not to the expression of cell adhesion proteins.
    Hahn-Strömberg V; Edvardsson H; Bodin L; Franzén L
    APMIS; 2009 Mar; 117(3):205-11. PubMed ID: 19245593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells.
    Gee J; Lee IL; Grossman HB; Sabichi AL
    Urol Oncol; 2008; 26(6):641-5. PubMed ID: 18367112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A reduced COX-2 expression and a reduced number of pericryptal myofibroblasts are associated with depressed adenoma of the colon.
    Harada K; Higaki S; Amano A; Hashimoto K; Hashimoto S; Gondo T; Sakaida I
    Oncol Rep; 2007 Jun; 17(6):1353-8. PubMed ID: 17487390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of tissue micro array in Duke's B colon cancer.
    Kjaer-Frifeldt S; Lindebjerg J; Brünner N; Garm Spindler KL; Jakobsen A
    APMIS; 2012 Oct; 120(10):819-27. PubMed ID: 22958290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the mucosa in the background of the lesion of colonic cancer.
    Mori Y
    Hokkaido Igaku Zasshi; 2006 Sep; 81(5):409-17. PubMed ID: 17096506
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclooxygenase-2 in Dukes B colon cancer.
    Sundov Z; Kunac N; Capkun V; Kalebić M; Druzijanić N; Puljak L; Tomić S
    Hepatogastroenterology; 2011; 58(107-108):763-8. PubMed ID: 21830386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.
    Karpisheh V; Nikkhoo A; Hojjat-Farsangi M; Namdar A; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Yousefi B; Jadidi-Niaragh F
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106338. PubMed ID: 31100474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.